Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Test/Monitoring
- Antibody
- Diagnostic
- Scientific & Technical Instruments
- Agriculture Forestry & Fishing
- Aquaculture
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 118864
Licensors sells to Licensee and Licensee buys from Licensors all transferable rights to use, manufacture and distribute the Licensed Product freely, indicating that these antibodies were developed by Licensors.
PSP means paralytic shellfish poisoning for the red tide detection kit. This antitoxin test system has enabled us to develop a PSP detection test for specific PSP toxins which can be used in specialized laboratories. This method, consistent with our methodology, will extract and analyze acid fluids from a shellfish to detect whether the shellfish contains specific PSP toxins.
IPSCIO Record ID: 113129
Licensee is interested in obtaining all transferable rights concerning the Licensed Products from Licensor in order to manufacture and to distribute the PSP ELISA Test under the Licensee's trade mark 'RIDASCREEN', co-exclusively, where and how Licensee sees fit, bearing the sole responsibility thereof.
Licensor sells to Licensee and Licensee buys from Licensor all transferable rights to use, manufacture and distribute the Licensed Product freely but indicating that these products were developed and/or obtained by Licensor.
The PSP ELISA Test Kit is a paralytic shellfish poisoning (PSP) red tide detection kit.
IPSCIO Record ID: 256630
The intellectual property of the antitoxin belongs exclusively to Licensor.
The intellectual and commercial property of the final product will be the common property of the Licensor and the Licensee at 50% each.